Pfizer Inc
PFE- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000078003
In the last 90 days, Pfizer Inc insiders filed 3 open-market purchases and 1 sale; 2,842 institutions reported holding it in 13F filings for Q2 2026, worth $91.9B in total; Fairfax Financial is the only superinvestor holding it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Pfizer Inc insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 3 filings
- 3 insiders, $2.96M in total
- Open-market sells
- 1 filing
- 1 insider, $83.3K in total
- Insiders trading
- 4
- Net value
- +$2.88M
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Pfizer Inc, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Bourla Albert | Chairman & CEO | 429,173 | Sep 16, 2026 | 28 |
| Damico Jennifer B. | SVP & Controller | 28,611 | Aug 6, 2026 | 6 |
| Blaylock Ronald E | Director | 66,938 | Aug 5, 2026 | 2 |
| Buckley Mortimer J | Director | 37,632 | Aug 5, 2026 | 5 |
| Narayen Shantanu | Director | – | Jun 30, 2026 | 5 |
| Taraporevala Cyrus | Director | – | Jun 30, 2026 | 5 |
| Quincey James | Director | – | Jun 30, 2026 | 5 |
| Smith James C | Director | – | Jun 30, 2026 | 5 |
| Echevarria Joseph | Director | – | Jun 30, 2026 | 5 |
| Nora Johnson Suzanne M | Director | – | Apr 27, 2026 | 1 |
| Gottlieb Scott | Director | 10,000 | Apr 27, 2026 | 1 |
| Desmond-Hellmann Susan | Director | – | Apr 27, 2026 | 1 |
| Littman Dan R. | Director | – | Apr 27, 2026 | 1 |
| Denton David M | Chief Financial Officer & EVP | 37,919 | Mar 5, 2026 | 1 |
| Fonseca Lidia | Executive Vice President | 46,455 | Mar 5, 2026 | 2 |
| Lankler Douglas M | Executive Vice President | 163,177 | Mar 5, 2026 | 2 |
| Sahni Payal | Executive Vice President | 27,667 | Mar 5, 2026 | 2 |
| Malik Aamir | Executive Vice President | 29,548 | Mar 5, 2026 | 1 |
| McDermott Michael | Executive Vice President | 74,308 | Mar 5, 2026 | 2 |
| Boshoff Christoffel | President, R&D | 161,379 | Mar 5, 2026 | 4 |
| de Germay Alexandre | Executive Vice President | 74,377 | Mar 5, 2026 | 1 |
| Baum Andrew | Executive Vice President | – | Mar 5, 2026 | 1 |
| Hockfield Susan | Director | – | Apr 28, 2025 | 0 |
| Susman Sally | Executive Vice President | 168,909 | Mar 6, 2025 | 0 |
| Johnson Rady A | Executive Vice President | 97,153 | Jan 3, 2025 | 0 |
| Dolsten Mikael | President R&D | 321,729 | Sep 16, 2024 | 0 |
| Hobbs Helen | Director | – | Apr 26, 2024 | 0 |
| Hwang Angela | President, Global Biopharma | 29,778 | May 11, 2023 | 0 |
| Pao William | Executive Vice President | 97,765 | Apr 3, 2023 | 0 |
| Carapezzi William R JR | Executive Vice President | 38,146 | May 13, 2022 | 0 |
| Damelio Frank A | Executive Vice President | 555,941 | Mar 1, 2022 | 0 |
| Young John D | Group President | 312,704 | Dec 16, 2021 | 0 |
| Mackenzie Alexander R | Executive Vice President | 87,280 | Dec 6, 2021 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 12, 2026 (view filing)4:04 PM ET | Aug 12 | Same day | Bourla AlbertChairman & CEO | PPurchase | +38.0K | $26.34 | +$1.00M | +9.7%429.2K after | |
| Aug 6, 2026 (view filing)11:26 AM ET | Aug 5 | 1 day | Damico Jennifer B.SVP & Controller | SSale | −3.28K | $25.40 | −$83.3K | −10.3%28.6K after | |
| Aug 5, 2026 (view filing)4:03 PM ET | Aug 5 | Same day | Blaylock Ronald EDirector | PPurchase | +39.2K | $25.46 | +$998.8K | +141.6%66.9K after | |
| Aug 5, 2026 (view filing)4:02 PM ET | Aug 5 | Same day | Buckley Mortimer JDirector | PPurchase | +37.6K | $25.52 | +$960.4K | New position37.6K after | |
| Jun 10, 2026 (view filing) | Jun 9 | 1 day | Damico Jennifer B.SVP & Controller | SSale | −2.00K | $25.70 | −$51.4K | −6.0%31.4K after | |
| Mar 6, 2025 (view filing) | Mar 4 | 2 days | Damico Jennifer B.SVP & Controller | SSale | −2.50K | $25.93 | −$64.8K | −17.4%11.8K after | |
| Feb 14, 2025 (view filing) | Feb 13 | 1 day | Blaylock Ronald EDirector | PPurchase | +19.5K | $25.65 | +$499.1K | +235.8%27.7K after | |
| Oct 31, 2024 (view filing) | Oct 30 | 1 day | Gottlieb ScottDirector | PPurchase | +1.00K | $28.24 | +$28.2K | +11.1%10.0K after | |
| Aug 14, 2024 (view filing) | Aug 13 | 1 day | Damico Jennifer B.SVP & Controller | SSale | −5.15K | $28.66 | −$147.7K | −37.5%8.58K after | |
| Dec 19, 2023 (view filing) | Dec 15 | 4 days | Gottlieb ScottDirector | PPurchase | +3.00K | $26.47 | +$79.4K | +50.0%9.00K after | |
| May 9, 2023 (view filing) | May 5-8 | 4 days | Gottlieb ScottDirector | PPurchase | +2.00K | $38.51 | +$77.0K | +50.0%6.00K after | 2 lots |
| Mar 17, 2023 (view filing) | Mar 15 | 2 days | Damico Jennifer B.SVP & Controller | SSale | −9.91K | $40.02 | −$396.7K | −52.4%9.00K after | |
| Jun 8, 2022 (view filing) | Jun 7 | 1 day | Damico Jennifer B.SVP & Controller | SSale | −4.22K | $53.96 | −$227.6K | −28.0%10.8K after | |
| May 17, 2022 (view filing) | May 16 | 1 day | Damico Jennifer B.SVP & Controller | SSale | −4.00K | $50.50 | −$202.0K | −21.0%15.1K after | |
| May 16, 2022 (view filing) | May 13 | 3 days | Sahni PayalExecutive Vice President | SSale | −1.41K | $49.84 | −$70.2K | −7.5%17.4K after | |
| May 13, 2022 (view filing) | May 12 | 1 day | Carapezzi William R JRExecutive Vice President | SSale | −32.9K | $50.00 | −$1.65M | −46.3%38.1K after | |
| May 13, 2022 (view filing) | May 12 | 1 day | Lankler Douglas MExecutive Vice President | SSale | −38.3K | $49.41 | −$1.89M | −32.7%78.8K after | |
| May 12, 2022 (view filing) | May 11 | 1 day | Dolsten MikaelPresident R&D | SSale | −63.9K | $49.32 | −$3.15M | −16.1%333.3K after | 6 lots |
| Dec 6, 2021 (view filing) | Dec 2 | 4 days | Mackenzie Alexander RExecutive Vice President | SSale | −41.4K | $54.26 | −$2.24M | −32.2%87.3K after | |
| Dec 6, 2021 (view filing) | Dec 3 | 3 days | Johnson Rady AExecutive Vice President | SSale | −19.0K | $53.42 | −$1.02M | −25.4%55.8K after | 11 lots |
| Nov 30, 2021 (view filing) | Nov 26 | 4 days | Lankler Douglas MExecutive Vice President | SSale | −40.0K | $54.37 | −$2.17M | −37.6%66.3K after | 12 lots |
| Nov 30, 2021 (view filing) | Nov 26 | 4 days | Susman SallyExecutive Vice President | SSale | −44.3K | $54.52 | −$2.42M | −33.1%89.6K after | 14 lots |
| Nov 15, 2021 (view filing) | Nov 11 | 4 days | Dolsten MikaelPresident R&D | SSale | −59.7K | $50.29 | −$3.00M | −17.6%279.8K after | 7 lots |
| Nov 15, 2021 (view filing) | Nov 12 | 3 days | Hwang AngelaGroup President | SSale | −26.2K | $49.60 | −$1.30M | −100.0%1 after | 4 lots |
| Nov 12, 2021 (view filing) | Nov 11 | 1 day | Young John DGroup President | SSale | −150.0K | $50.06 | −$7.51M | −32.4%312.7K after | 11 lots |
| Aug 16, 2021 (view filing) | Aug 13 | 3 days | Damico Jennifer B.SVP & Controller | SSale | −1.66K | $48.30 | −$80.2K | −14.5%9.77K after | 2 lots |
| Aug 2, 2021 (view filing) | Jul 30 | 3 days | Damico Jennifer B.SVP & Controller | SSale | −2.50K | $42.86 | −$107.2K | −17.9%11.4K after |